• Login
• Admin

2016

Flume, Patrick, VanDevanter, Donald R., Morgan, E.E., Dudley, Michael N., Loutit, Jeffery S., Bell, Scott C., Kerem, Eitan, Fischer, R., Smyth, Alan R., Aaron, Shawn D., Conrad, Douglas, Geller, David E. and Elborn, J. Stuart (2016) A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 15 . pp. 495-502. ISSN 1873-5010

2015

Freschi, Luca, Jeukens, Julie, Kukavica-Ibrulj, Irena, Boyle, Brian, Dupont, Marie-Josée, Laroche, Jérôme, Larose, Stéphane, Maaroufi, Halim, Fothergill, Joanne L., Moore, Matthew, Winsor, Geoffrey L., Aaron, Shawn D., Barbeau, Jean, Bell, Scott C., Burns, Jane L., Cámara, Miguel, Cantin, André, Charette, Steve J., Dewar, Ken, Déziel, Éric, Grimwood, Keith, Hancock, Robert E.W., Harrison, Joe J., Heeb, Stephan, Jelsbak, Lars, Jia, Baofeng, Kenna, Dervla T., Kidd, Timothy J., Klockgether, Jens, Lam, Joseph S., Lamont, Iain L., Lewenza, Shawn, Loman, Nick, Malouin, François, Manos, Jim, McArthur, Andrew G., McKeown, Josie, Milot, Julie, Naghra, Hardeep, Nguyen, Dao, Pereira, Sheldon K., Perron, Gabriel G., Pirnay, Jean-Paul, Rainey, Paul B., Rousseau, Simon, Santos, Pedro M., Stephenson, Anne, Taylor, Véronique, Turton, Jane F., Waglechner, Nicholas, Williams, Paul, Thrane, Sandra W., Wright, Gerard D., Brinkman, Fiona S.L., Tucker, Nicholas P., Tümmler, Burkhard, Winstanley, Craig and Levesque, Roger C. (2015) Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Frontiers in Microbiology, 6 (1036). pp. 1-8. ISSN 1664-302X

Elborn, J. Stuart, Geller, David E., Conrad, Douglas, Aaron, Shawn D., Smyth, Alan R., Fischer, Rainald, Kerem, Eitan, Bell, Scott C., Loutit, Jeffery S., Dudley, Michael N., Morgan, Elizabeth E., VanDevanter, Donald R. and Flume, Patrick (2015) A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 14 (4). pp. 507-514. ISSN 1873-5010